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Infected aneurysms of the suprarenal
abdominal aorta
Ron-Bin Hsu, MD, Chung-I Chang, MD, Chih-Yang Chan, MD, and I-Hui Wu, MD, Taipei, Taiwan
Background: Infected aneurysm of the suprarenal abdominal aorta is rare and can be fatal without surgery. There have
been only sporadic case reports or small case series. We review our experience with 14 patients over 13 years.
Methods: Retrospective chart review.
Results: Between 1997 and 2010, 14 cases of infected aneurysms of the suprarenal abdominal aorta were treated at our
hospital. There were 11 men with median age of 75.5 years (range, 35-88). Of the 13 pathogens isolated, the most
common responsible microorganism was nontyphoid Salmonella in eight (62%) followed by Staphylococcus aureus in three
(23%) and Streptococcus in two patients (15%). At the first admission, six patients hadmedical treatment alone, five patients
underwent early open in situ graft repair, and three patients underwent hybrid endovascular stenting and visceral
debranching. Of the six medically treated patients, two patients died in the hospital because of aneurysm rupture, and two
patients underwent late open in situ graft repair because of aneurysm progression or rupture. Of the five open surgically
treated patients, one patient died in the hospital because of nosocomial sepsis, and four patients were alive without major
postoperative complication. Of the three endovascularly treated patients, one patient died in the hospital because of
intestinal ischemia, one patient died 6 months later because of postoperative complication, and one patient was alive with
complications of paraplegia, renal failure, and permanent dialysis. The aneurysm-related mortality rate was 33% (2/6) in
medical treatment alone, 20% (1/5) in open in situ grafting, and 67% (2/3) in hybrid endovascular stenting.
Conclusions: Infected aneurysm of the suprarenal abdominal aorta was rare. Nontyphoid Salmonella was the most
common responsible microorganism. Open in situ graft repair remained a preferred and durable treatment strategy.
(J Vasc Surg 2011;54:972-8.)
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tInfected aneurysm of the aorta and adjacent arteries is a
rare but life-threatening condition.1-5 The mortality rate is
extremely high without surgical treatment. The reported
hospital mortality rates of surgical treatment ranged from
16% to 44%.1-5 Hospital survival was poor in those patients
with severe aortic infection, presence of aneurysm rupture
and, especially, suprarenal infection.1-5 Infected aneurysm
of the suprarenal abdominal aorta is even rare. There have
been only sporadic case reports or small case series.6-14
Infected aortic aneurysm is common inTaiwan andHong
Kong.15-22 We have reported that with timely surgical inter-
vention and prolonged intravenous antibiotic, surgery with in
situ graft replacement provides a good outcome.17-21 How-
ever, only seven cases of infected suprarenal abdominal aortic
aneurysmwere reported then. The clinical presentation, treat-
ment, and outcome are not clear. Here, we review our expe-
riencewith 14patients of infected suprarenal abdominal aortic
aneurysm over 13 years.
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972ATIENTS AND METHODS
Setting. National Taiwan University Hospital (Taipei,
aiwan) is a 2200-bed tertiary care hospital. It serves an urban
opulation of 2 million persons as both first-line and tertiary
acilities. It serves also as a referral center for other hospitals in
he country with a population of 23 million persons.
Patients. The study patient cohort was obtained from
retrospective analysis of the clinical data for patients with
nfected aneurysms of the suprarenal abdominal aorta from
ovember 1997 to November 2010. Patients with infec-
ion of infrarenal abdominal aorta were excluded.
Diagnosis. The diagnosis of infected aneurysm was
ade by a combination of clinical evidence of infection, im-
ging evidence of infected aorta, and/or pathologic evidence
f inflammation. Clinically, infected aortic aneurysmwas usu-
lly preceded by infected aorta or aortitis. Infected aorta was
iagnosed with clinical evidence of infection (fever and leuko-
ytosis) and periaortic soft tissue infiltration demonstrated by
maging studywith either computed tomography ormagnetic
esonance imaging.23 Blood and tissue culture was repeated
o find the responsible microorganism. The diagnosis of in-
ected aneurysm was further confirmed by the presence of
rank pus during operation, and the presence of acute suppura-
ive inflammation and/or bacterial clumps on pathologic exam-
nation.24
All patients with infected aneurysms were advised to un-
ergo surgery. Open repair was performed before 2007. We
tarted to perform hybrid endovascular repair since 2007.
Medical treatment. As described previously,17-21 in-
ravenous antibiotic was given once the diagnosis was con-
rmed. For patients with Salmonella species infections,
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Volume 54, Number 4 Hsu et al 973intravenous ceftriaxone (1000 to 2000 mg q12 h) was
used. For patients with non-salmonella infections, antibi-
otic was used based on culture result and sensitivity test. In
patients with good response to antibiotic treatment (no
fever, no localized pain, and declining white cell count),
surgical intervention was considered after the infection was
controlled. Imaging study was repeated if patients had a
new symptom or sign suggesting aortic pseudoaneurysm
formation (shock, a new localized pain, or a new palpable
mass) or after complete antibiotic treatment for 4 to 6
weeks. Early surgical intervention, which was defined as
operation before the infection was controlled (no fever and
declining white cell count), was performed only in the
situations of uncontrolled infection (persistent fever or
septic shock) or evidences of impending aortic rupture
(persistent pain, shock, or enlarging pseudoaneurysm for-
mation on the repeated imaging study).
Open repair. Surgical management consisted of wide
debridement of infected tissue, copious saline irrigation,
and in situ repair with a Dacron graft.17-21 Homograft or
antibiotic-immersed graft was not used. The selected oper-
ative approach depended on the surgeon’s preference. The
celiac, superior mesenteric, and renal arteries were reim-
planted as an island flap if necessary.
Hybrid endovascular repair. A hand-made multi-
branched Dacron graft was used to sequentially bypass, in
extra-anatomic manner, the renal arteries, superior mesen-
teric artery, and common hepatic artery. Inflow was
through a single proximal anastomosis to the iliac artery.
Table I. Patient data of infected aneurysms of the suprare
No. Sex
Age in
years Pathogen
1 F 35 Salmonella choleraesuis
2 M 53 Salmonella enteritidis
3 M 59 Salmonella choleraesuis
4 M 86 Salmonella enteritidis
5 F 85 Streptococcus Group F
6 M 88 Staphylococcus aureus
7 M 76 Salmonella typhimurium
8 M 85 Salmonella choleraesuis
9 F 67 Staphylococcus aureus
10 M 59 Salmonella enteritidis
11 M 83 Unknown
12 M 81 Staphylococcus aureus
13 M 72 Streptococcus pneumoniae
14 M 75 Salmonella enteritidisStent-graft devices with Tag or Zenith (Cook Inc, Bloom- angton, Ind) were introduced via a transverse arteriotomy
ver the common femoral artery and deployed to cover the
nfected aneurysm. Intraoperative aortogram confirmed
atisfactory positioning of the endografts with complete
ealing of the pseudoaneurysm sac and patency of individ-
al bypass grafts.
Antibiotics were administered intravenously in the hos-
ital for at least 6 to 8 weeks and until the clinical and
aboratory parameters (fever, white cell count, and C-
eactive protein) were normalized. Antibiotic continued
rally after discharge with the duration of at least 6 months.
Data collection. Data on age, sex, medical comorbidi-
ies, operation status, surgical procedure, and clinical out-
ome were collected retrospectively from medical records.
ajor postoperative complication was defined as aortic
ranch injury, including paraplegia, acute renal failure,
owel ischemia, and limb ischemia. Aneurysm-relatedmor-
ality was defined as a mortality caused by persistent infec-
ion or postoperative complications directly related to op-
ration. Themortality was caused by a diagnosis not related
nfected aneurysm or the mortality, which occurred 6
onths after operation was considered not aneurysm-
elated. The National Death Index, hospital computerized
ecords, or telephone follow-up were used to verify the
atient outcome.
ESULTS
Patient characteristics. From 1997 to 2010, 14 pa-
ients with infected aneurysms of the suprarenal abdominal
bdominal aorta (n  14)
Clinical presentation Medical diseases
ever Systemic lupus erythematosus,
osteomyelitis
ever HT
ever, abdominal pain ESRD HD, thrombocytopenia
ever, abdominal pain DM, HT
ever, abdominal pain None
ever, loss of consciousness HT, chest trauma, empyema
ever DM, HT, CAD, chronic renal
insufficiency
ever, abdominal pain HT, acute renal failure
ever, abdominal pain HT, dementia
ever, abdominal pain DM, HT
ever ESRD, bladder carcinoma,
CAD
ever, abdominal pain HT
ever None
ever DM, HT, ESRD HDnal a
F
F
F
F
F
F
F
F
F
F
F
F
F
Forta were treated at our hospital. The patient demograph-
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October 2011974 Hsu et alics are shown in Table I. There were 11 men and 3 women
with median age of 75.5 years (range, 35-88). The medical
comorbidities included hypertension in 9 patients, diabetes
mellitus in 4 patients, end-stage renal disease with regular
hemodialysis in 3 patients, coronary artery disease in 2
patients and systemic lupus erythematosus in 1 patient.
Of the 14 patients, 14 patients were febrile at presen-
tation and seven patients had localized abdominal or back
pain. One patient was in confused consciousness at the time
of presentation. The initial imaging findings were aortic
pseudoaneurysm or saccular aneurysm in 14 patients. The
size of pseudoaneurysm or saccular aneurysm ranged from
2 to 6.3 cm in maximal diameter (Table I).
Microbiology. All patients had a positive blood or
tissue culture except in onemedically treated patient (Table
I). Of the 13 pathogens isolated, the most common re-
sponsible microorganism was nontyphoid Salmonella in
eight (62%) followed by Staphylococcus aureus in three
(23%) and Streptococcus in two patients (15%). The sero-
types of isolated nontyphoid Salmonellas were Salmonella
cholerasuis in three, Salmonella enteritidis in four, and
Salmonella typhimurium in one patient.
Treatment. At the first admission, 6 patients received
medical treatment alone because of old age in 3 patients,
severe medical comorbidities in 2 patients and simple pa-
tient refusal in 1 patient (Table I). Five patients underwent
open in situ graft repair (Table I). The duration of preop-
erative antibiotic use was 0, 0, 1, 7, and 28 days, respec-
Table I. Continued.
Size of
aneurysm Operation and branch bypassed Hospita
4.5 cm None Alive
2 cm In situ grafting; no bypass; CPB
()
Alive
5 cm Patch repair; no bypass; CPB () Alive
5 cm None Died aneur
6 cm In situ grafting; no bypass; CPB
()
Alive
6 cm None Died aneur
4 cm None Alive
4 cm In situ grafting; left renal artery;
CPB ()
Died sepsis
5 cm In situ grafting; celiac/SMA/right
renal artery, left renal artery;
CPB ()
Alive
5.6 cm None Alive
3.6 cm None Alive
5 cm Visceral debranching and
endovascular grafting (Zenith)
Alive
4 cm Visceral debranching and
endovascular grafting (Zenith)
Alive
6.3 cm Visceral debranching and
endovascular grafting (Tag)
Died
CAD, Coronary artery disease; CPB, cardiopulmonary bypass; DM, diabetetively. Three patients underwent hybrid endovascular stent- png and visceral debranching (Table I). The duration of
reoperative antibiotic use was 2, 4, and 18 days, respec-
ively. The treatment method, operation details, and clini-
al outcome were summarized in the Fig.
Clinical outcome. Of the six medically treated pa-
ients, two died in the hospital because of aneurysm rupture
1 and 40 days after admission (Fig, Table I). Two patients
nderwent a successful late in situ graft replacement 6
onths and 8 years later because of aneurysm rupture or
neurysm enlargement. They were alive and well. Two
atients died of not aneurysm-related causes 17 and 21
onths later.
Of the five surgically treated patients, one patient died
n the hospital because of nosocomial sepsis and four pa-
ients were alive with no major postoperative complication
Fig, Table I). Hospital death occurred in an 85-year-old
ale with infected aneurysm caused by Salmonella cholera-
uis. He underwent an early operation after the preopera-
ive use of ceftriaxone for 7 days. The postoperative course
as complicated with renal failure, respiratory failure, and
ecurrent nosocomial infection. He died of Candida tropi-
alis sepsis 2 months after operation. Of the 4 operated
urvivors, there were 3 late mortalities not related to aneu-
ysm: 2 heart diseases and 1 colon cancer. The follow-up
uration ranged from 30 to 52 months.
Of the 3 endovascularly treated patients, 1 patient died
n the hospital because of bowel ischemia, 1 patient died
fter discharge because of postoperative complication and 1
ome
Postoperative
complication Late outcome
Aneurysm rupture and
grafting 8 years after
None Died 52 months heart
disease
None Died 48 months colon
cancer
upture
None Died 43 months heart
disease
upture
Died 21 months heart
disease
None Alive 30 months
Grafting 6 months after
Died 17 months organ
failure
Acute renal failure, ileus Died 6 months organ
failure
Acute renal failure,
paraplegia
Alive 29 months
Bowel ischemia
itus; ESRD HD, end-stage renal disease hemodialysis; HT, hypertension.l outc
ysm r
ysm ratient was alive with major complications of paraplegia,
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tal death occurred in a 75-year-old male with end-stage
renal failure and permanent dialysis. He had an infected
aneurysm caused by Salmonella enteritidis. He underwent
an early hybrid endovascular stenting and visceral
debranching (celiac and superior mesenteric arteries) after
the preoperative use of ceftriaxone for 2 days. However, he
died of bowel ischemia 4 days after operation. Late
aneurysm-related mortality occurred in an 81-year-old
male with an infected aneurysm caused by Staphylococcus
aureus. He underwent a hybrid endovascular stenting and
visceral debranching (celiac, superior mesenteric, and renal
arteries) after the preoperative use of oxacillin for 18 days.
Postoperative course was complicated with renal failure,
uremic encephalopathy, and multiple episodes of nosoco-
mial infection. He was hospitalized for 5 months and
discharged to a nursing home. He died of renal failure 6
months after operation. The hospital survivor was a 72-
year-old male with an infected aneurysm caused by Strep-
tococcus pneumoniae. He underwent a hybrid endovascular
stenting and visceral debranching (celiac, superior mesen-
teric, and renal arteries) after the preoperative use of teico-
planin for 4 days. Postoperative course was complicated
with paraplegia, renal failure and permanent dialysis.
In summary, the aneurysm-related mortality rate was
33% (2/6) in medical treatment alone, 20% (1/5) in open
in situ grafting, and 67% (2/3) in hybrid endovascular
stenting. The rate of free from death and major postoper-
ative complications was 80% (4/5) in patients undergoing
open in situ grafting and 0% in patients undergoing hybrid
Fig. Treatment and outcome in patients with inendovascular repair (Table II). bISCUSSION
Infected aneurysm of the suprarenal abdominal aorta is
xtremely rare. The clinical experience is obtained from
ase reports, small series, and literature review.6-14 In situ
rosthetic reconstruction, accompanied by thorough de-
ridement, prolonged antibiotic therapy, and probably life-
ong suppressive oral antibiotics, offers the best chance for
urvival.10,12,13 The reported hospital mortality of open in
itu repair is 20%.6-14 Survival is poor in extra-anatomic
econstruction.12 However, a review based on several case
eports or literature review may, however, be subject to
ublication bias resulting in a falsely high survival rate.12
Open or hybrid repair. Surgical treatment of thora-
oabdominal aortic aneurysms is challenging. The cause of
horacoabdominal aortic aneurysm is mostly degenerative
nd not infected. The reported hospital mortality of open
epair usually exceeds 20%.25,26 Hybrid endovascular repair
hen plays a role in the treatment of patients who suffer
rom thoracoabdominal aortic aneurysms but are unfit for
pen repair. Hybrid endovascular repair combines both
pen renovisceral debranching and endovascular stenting.
his consists of an open operation in which the visceral
rteries of the abdominal aorta are debranched via extra-
natomic bypass grafts originating from the distal abdom-
nal aorta or iliac arteries. It provides a landing zone for
ubsequent placement of an endograft. Although hybrid
ndovascular repair avoids aortic cross-clamping and two-
avity thoracoabdominal approach, it is time-consuming
ith a significant number and technically demanding anas-
omoses to the visceral vessels and is usually associated with
d aneurysms of the suprarenal abdominal aorta.ypass-related complications such as renal failure, intestinal
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repair is reserved for patients considered to be at a high risk
for standard open thoracoabdominal repair.25
Infected aneurysm. Infected aortic aneurysm is a ther-
apeutic challenge. Endovascular repair in this indication is still
disputed. Endovascular treatment of infected aortic aneurysm
provides a valid alternative to open repair but may be unsuc-
cessful owing to persistent infection. Previous authors have
reported their experiences with early and late results of endo-
vascular repair in infected aneurysm. But these outcomes have
been mixed.27-31 Although endovascular repair provides an
early survival benefit, the late mortality rate can exceed
40%.27-31 Endovascular repair of suprarenal infected abdom-
inal aortic aneurysm is evenmore complex because a concom-
itant renovisceral debanching is usually required. Clinical ex-
perience of endovascular repair of suprarenal infected
abdominal aortic aneurysm is extremely rare. A total of six
Table II. Comparisons between treatment groups
Variables
Number
Median age in years (range) 7
Male
ESRD dialysis
Diabetes mellitus
Fever at presentation
Hypotension at presentation
Severe sepsis
Salmonella infection
Emergency operation
Aneurysm-related mortality
Free from aneurysm-related death or major complications
Median survival duration in months
ESRD, End-stage renal disease.
aTwo patients requiring late operation because of aneurysm progression or
Table III. Endovascular repair of infected suprarenal abdo
current series (n  3)
No.
Author
(country)
Age in
years Pathogen Branch b
1 Madhavan
(Ireland)
50 Staphylococcus None
2 Liu (Korea) 42 Mycobacterium
tuberculosis
None
3 Soule (France) 69 Escherichia coli Celiac ar
4 Sörelius
(Sweden)
77 Mycobacteria None
5 Sörelius
(Sweden)
77 Mycobacteria None
6 Sörelius
(Sweden)
68 Salmonella Celiac, S
renal a
7 Hsu (Taiwan) 81 Staphylococcus
aureus
Celiac, S
renal a
8 Hsu (Taiwan) 72 Streptococcus
pneumoniae
Celiac, S
renal a
9 Hsu (Taiwan) 75 Salmonella
enteritidis
Celiac an
SMA, Superior mesenteric artery.cases have been reported in the English literature (Table tII).30,32-34 Only two of them were alive and free frommajor
ostoperative complications. The largest case series of three
ndovascular repairs of infected suprarenal abdominal aortic
neurysms were reported by Sörelius et al in 2009.30 Their
esult was not satisfactory. Two patients died of intestinal
schemia and sepsis. One patient was alive but suffered from
ecurrent infection (Table III). Here, we have a similar result.
one of our patients undergoing hybrid endovascular repair
as free from death or major postoperative complication.
In hybrid endovascular repair of thoracoabdominal aneu-
ysms, there is a trend toward fewer postoperative complica-
ions in those patients requiring fewer renovisceral bypass
rafts.35 In open repair of infected suprarenal abdominal
ortic aneurysms, the number of renovisceral bypasses is usu-
lly few because the extent of disease is usually limited to a
hort aortic segment. In our patients (Table I), 3 of 5 open
urgically treated patients had no bypass graft. However, all of
cal alone Open repair Hybrid endovascular repair
6 5 3
35 to 88) 67 (53 to 85) 75 (72 to 81)
83%) 3 (60%) 3 (100%)
17%) 1 (20%) 1 (33%)
50%) 0 (0%) 1 (33%)
100%) 5 (100%) 3 (100%)
0%) 0 (0%) 0 (0%)
17%) 0 (0%) 0 (0%)
67%) 3 (60%) 1 (33%)
2 (40%) 0 (0%)
33%) 1 (20%) 2 (67%)
67%) 4 (80%) 0 (0%)
19 48 6
e.
al aortic aneurysms in the literature (n  6) and this
ed
Hospital
outcome
Postoperative
complication Late outcome
Alive Paraplegia, renal failure,
intestinal ischemia
Alive 12 months
Alive None Alive 12 months
Alive None Alive 18 months
Died Intestinal ischemia
Died Sepsis
nd
s
Alive Sepsis Alive 15 months
nd
s
Alive Renal failure, ileus Died 6 months
organ failure
nd
s
Alive Renal failure, paraplegia Alive 29 months
A Died Intestinal ischemiaMedi
9.5 (
5 (
1 (
3 (
6 (
0 (
1 (
4 (
2 (
4a (min
ypass
tery
MA a
rterie
MA a
rterie
MA a
rterie
d SMhe 3 endovascularly treated patients required 2 to 4 bypass
11
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
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was fewer in open surgically treated patients than in endovas-
cularly treated patients. Severe medical comorbidities, persis-
tent infection, and need of extensive renovisceral bypass con-
tributed to a significant mortality and morbidity of hybrid
endovascular repair in these patients. Although hybrid endo-
vascular repair could be an alternative in sick patients, the
experience in this small series is uniformly poor, with two
deaths out of three patients and multiple procedure-related
complications in the lone survivor.Hybrid endovascular repair
of infected suprarenal abdominal aortic aneurysms has signif-
icant morbidity and mortality suggesting open repair remains
a standard treatment strategy.
Study limitation. The major limitations of this study
are a retrospective study and a long time span. There are
many differences in patients and their clinical presentations
that could account for these differences, rather than the
treatment approach (Table II). In addition, certain novel
techniques of hybrid endovascular repair of thoracoab-
dominal aneurysm are not employed in this study. How-
ever, this study is the largest case series of infected suprare-
nal abdominal aortic aneurysm and provides useful
information in management of these high-risk patients.
In conclusion, infected aneurysm of suprarenal abdom-
inal aorta was rare. Nontyphoid Salmonella was the most
common responsible microorganism. Open in situ graft
repair remained a preferred and durable treatment strategy.
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